CERO THERAPEUTICS HOLDINGS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CERO THERAPEUTICS HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $244.32K, a 49.31% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $456.17K.
- CERO THERAPEUTICS HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $1.28M.
- CERO THERAPEUTICS HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $481.97K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $244.32K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $456.17K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $1.28M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $481.97K 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |